X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STRIDES PHARMA SCIENCE - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STRIDES PHARMA SCIENCE J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 16.6 23.2 71.7% View Chart
P/BV x 2.1 1.0 210.5% View Chart
Dividend Yield % 0.6 0.5 115.0%  

Financials

 J.B.CHEMICALS   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3631,147 31.7%   
Low Rs255642 39.7%   
Sales per share (Unadj.) Rs169.1317.2 53.3%  
Earnings per share (Unadj.) Rs16.67.8 211.6%  
Cash flow per share (Unadj.) Rs23.425.1 93.5%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.60.2 289.4%  
Book value per share (Unadj.) Rs172.5274.3 62.9%  
Shares outstanding (eoy) m83.5789.50 93.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.8 64.8%   
Avg P/E ratio x18.6114.0 16.3%  
P/CF ratio (eoy) x13.235.7 37.0%  
Price / Book Value ratio x1.83.3 54.9%  
Dividend payout %12.025.5 47.3%   
Avg Mkt Cap Rs m25,82780,058 32.3%   
No. of employees `0003.82.5 150.5%   
Total wages/salary Rs m2,5114,341 57.9%   
Avg. sales/employee Rs Th3,747.411,325.8 33.1%   
Avg. wages/employee Rs Th665.71,731.4 38.4%   
Avg. net profit/employee Rs Th367.8280.1 131.3%   
INCOME DATA
Net Sales Rs m14,13528,394 49.8%  
Other income Rs m366941 38.9%   
Total revenues Rs m14,50129,334 49.4%   
Gross profit Rs m2,1783,965 54.9%  
Depreciation Rs m5701,540 37.0%   
Interest Rs m351,962 1.8%   
Profit before tax Rs m1,9401,403 138.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m55297 567.6%   
Profit after tax Rs m1,387702 197.6%  
Gross profit margin %15.414.0 110.3%  
Effective tax rate %28.56.9 410.7%   
Net profit margin %9.82.5 396.9%  
BALANCE SHEET DATA
Current assets Rs m10,47024,836 42.2%   
Current liabilities Rs m2,74918,993 14.5%   
Net working cap to sales %54.620.6 265.4%  
Current ratio x3.81.3 291.3%  
Inventory Days Days5571 77.8%  
Debtors Days Days78113 68.5%  
Net fixed assets Rs m5,81134,289 16.9%   
Share capital Rs m167895 18.7%   
"Free" reserves Rs m14,24823,651 60.2%   
Net worth Rs m14,41624,546 58.7%   
Long term debt Rs m015,513 0.0%   
Total assets Rs m17,64965,437 27.0%  
Interest coverage x56.61.7 3,298.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 184.6%   
Return on assets %8.14.1 197.9%  
Return on equity %9.62.9 336.4%  
Return on capital %13.76.9 198.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16415,697 39.3%   
Fx outflow Rs m1,334735 181.5%   
Net fx Rs m4,82914,962 32.3%   
CASH FLOW
From Operations Rs m1,2311,871 65.8%  
From Investments Rs m-2085,826 -3.6%  
From Financial Activity Rs m-595-10,157 5.9%  
Net Cashflow Rs m427-2,615 -16.3%  

Share Holding

Indian Promoters % 55.4 27.7 200.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 37.8 9.0%  
FIIs % 3.9 8.6 45.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.9 142.9%  
Shareholders   30,437 56,241 54.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DIVIS LABORATORIES  GLENMARK PHARMA  SUN PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 300 Points Higher; Energy and Metal Stocks Witness Buying(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

This Little-Known Opportunity Promises Both Health and Wealth for Your Grandchildren(Profit Hunter)

Jun 20, 2019

The next big opportunity that has the potential to make you both rich and healthy.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 25, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - TTK HEALTHCARE COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS